Oncology Institute (TOI) Depreciation & Amortization (CF) (2021 - 2026)

Oncology Institute (TOI) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $1.6 million, down 9.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.8 million (up 2.95% YoY), and the FY2025 annual result was $6.9 million, up 10.45% from the prior year.
• Depreciation & Amortization (CF) was $1.6 million for Q1 2026 at Oncology Institute, down from $1.6 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.8 million in Q2 2025 and troughed at $987000.0 in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $1.5 million, with a median of $1.6 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) surged 49.74% in 2023 and decreased 9.42% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $1.2 million in 2022, then jumped by 32.3% to $1.6 million in 2023, then gained by 8.24% to $1.7 million in 2024, then decreased by 4.39% to $1.6 million in 2025, then slipped by 0.98% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.